Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35241665.
- Also identified by DOI 10.1038/s41467-022-28799-3 and PMC identifier 8894386.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of non-Hodgkin lymphoma distinguished by the presence of clonal malignant T cells. The heterogeneity of malignant T cells and the complex tumor microenvironment remain poorly characterized. With single-cell RNA analysis and bulk whole-exome sequencing on 19 skin lesions from 15 CTCL patients, we decipher the intra-tumor and inter-lesion diversity of CTCL patients and propose a multi-step tumor evolution model. We further establish a subtyping scheme based on the molecular features of malignant T cells and their pro-tumorigenic microenvironments: the T<sub>CyEM</sub> group, demonstrating a cytotoxic effector memory T cell phenotype, shows more M2 macrophages infiltration, while the T<sub>CM</sub> group, featured by a central memory T cell phenotype and adverse patient outcome, is infiltrated by highly exhausted CD8<sup>+</sup> reactive T cells, B cells and Tregs with suppressive activities. Our results establish a solid basis for understanding the nature of CTCL and pave the way for future precision medicine for CTCL patients.
Medical subject headings
- Lymphoma, T-Cell, Cutaneous
- Skin Neoplasms